Evidence Feed

About

Diagnostics

New

Top genes

FAQ

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

NIB103

ⁱ

Other names: NIB103, TAK-103, NIB-103

News alerts, weekly reports and conference planners

Associations

News

Trials

Company:

Noile-Immune Biotech

Drug class:

Mesothelin-targeted CAR-T immunotherapy

Related drugs:

‹

MSLN-CAR-T cell therapy (3)

CD40 ligand expressing MSLN-CAR T (0)

GC008t (0)

GPC3/Mesothelin/Claudin18.2/GUCY2C/B7-H3/PSCA/PSMA/MUC1/TGFβ/HER2/Lewis-Y/AXL/EGFR-CAR-T cells (0)

Mesothelin/GPC3/GUCY2C-CAR-T (0)

anti- MESO CAR-T cells (0)

anti-mesothelin CAR T cells (0)

iCasp9M28z T cell infusion (0)

meso-CART (0)

mesothelin-targeted CAR-T immunotherapy (0)

multi-target gene-modified CAR-T/TCR-T cell immunotherapy (0)